valproic acid has been researched along with Adenoma, Prolactin-Secreting, Pituitary in 2 studies
Valproic Acid: A fatty acid with anticonvulsant and anti-manic properties that is used in the treatment of EPILEPSY and BIPOLAR DISORDER. The mechanisms of its therapeutic actions are not well understood. It may act by increasing GAMMA-AMINOBUTYRIC ACID levels in the brain or by altering the properties of VOLTAGE-GATED SODIUM CHANNELS.
valproic acid : A branched-chain saturated fatty acid that comprises of a propyl substituent on a pentanoic acid stem.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Fifteen patients with prolactinomas, 8 patients with non-tumoral hyperprolactinemia and 10 healthy subjects were studied: in non consecutive days, all subjects received placebo and SV at the dose of 400 and 800 mg po." | 2.68 | Different sensitivity to sodium valproate in healthy, non-tumoral and tumoral hyperprolactinemic subjects. ( Colao, A; Di Sarno, A; Di Somma, C; Ferone, D; Landi, ML; Lombardi, G; Merola, B; Sarnacchiaro, F; Tolino, A, 1997) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gupta, P | 1 |
| Tundup, T | 1 |
| Singh, J | 1 |
| Deb, KS | 1 |
| Verma, R | 1 |
| Kumar, N | 1 |
| Sarnacchiaro, F | 1 |
| Colao, A | 1 |
| Merola, B | 1 |
| Di Sarno, A | 1 |
| Landi, ML | 1 |
| Di Somma, C | 1 |
| Ferone, D | 1 |
| Tolino, A | 1 |
| Lombardi, G | 1 |
1 trial available for valproic acid and Adenoma, Prolactin-Secreting, Pituitary
| Article | Year |
|---|---|
Different sensitivity to sodium valproate in healthy, non-tumoral and tumoral hyperprolactinemic subjects.
Topics: Adolescent; Adult; Female; GABA Agents; gamma-Aminobutyric Acid; Humans; Hyperprolactinemia; Kinetic | 1997 |
1 other study available for valproic acid and Adenoma, Prolactin-Secreting, Pituitary
| Article | Year |
|---|---|
Treatment complexities in psychosis associated with cabergoline treatment in patients having pituitary prolactinomas.
Topics: Adult; Cabergoline; Dopamine Agonists; Female; GABA Agents; Humans; Pituitary Neoplasms; Prolactinom | 2018 |